nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adding interferon-alfa to radiation therapy and carmustine does not improve survival rates in people with high-grade glioma
|
Prados, Michael |
|
2002 |
3 |
1 |
p. 36-38 3 p. |
artikel |
2 |
Adding prolonged asparaginase therapy to standard treatment may improve event-free survival among children with acute lymphoblastic leukemia
|
Matsuzaki, Akinobu |
|
2002 |
3 |
1 |
p. 41-42 2 p. |
artikel |
3 |
Compared to tamoxifen, letrozole increases tumor response in post-menopausal women with advanced breast cancer
|
Sivasubramaniam, Visaharan |
|
2002 |
3 |
1 |
p. 14-16 3 p. |
artikel |
4 |
Compared to tamoxifen, letrozole increases tumor response in post-menopausal women with estrogen-receptor-positive primary breast cancer
|
Sivasubramaniam, Visaharan |
|
2002 |
3 |
1 |
p. 29-30 2 p. |
artikel |
5 |
Docetaxel plus cisplatin or carboplatin is as effective, but may be safer and more practical than vinorelbine plus cisplatin for treating non-small cell lung cancer
|
Berghmans, T. |
|
2002 |
3 |
1 |
p. 39-40 2 p. |
artikel |
6 |
EDITORIAL
|
Djulbegovic, Associate Professor Benjamin |
|
2002 |
3 |
1 |
p. 1- 1 p. |
artikel |
7 |
Fluorouracil plus leucovorin improves survival compared with fluorouracil plus levamisole following curative resection of stage III colon cancer
|
Focan, C. |
|
2002 |
3 |
1 |
p. 43-45 3 p. |
artikel |
8 |
Gail et al risk prediction model adequately estimates breast cancer risk in groups of women but has lower accuracy for individual women
|
Pharoah, Paul |
|
2002 |
3 |
1 |
p. 12-13 2 p. |
artikel |
9 |
Glossary of terms
|
|
|
2002 |
3 |
1 |
p. 48-49 2 p. |
artikel |
10 |
Graft-vs-host disease: what is the evidence?
|
Fleming, Donald R. |
|
2002 |
3 |
1 |
p. 2-6 5 p. |
artikel |
11 |
Individually optimized regimen of intravesical mitomycin C reduces superficial bladder tumor recurrence compared with a standard regimen
|
Cliff, Andrew |
|
2002 |
3 |
1 |
p. 31-33 3 p. |
artikel |
12 |
Letrozole improves survival compared with megestrol acetate among women with advanced breast cancer
|
Costa, Serban D. |
|
2002 |
3 |
1 |
p. 34-35 2 p. |
artikel |
13 |
LHRH agonists are more effective when combined with tamoxifen for advanced premenopausal breast cancer
|
Bundred, N. |
|
2002 |
3 |
1 |
p. 17-18 2 p. |
artikel |
14 |
Pegylated liposmal doxorubicin prolongs survival compared to topotecan as second-line treatment in women with platinum-sensitive ovarian cancer
|
Hoskins, Paul J. |
|
2002 |
3 |
1 |
p. 21-23 3 p. |
artikel |
15 |
Pravastatin prolongs survival in people with advanced hepatocellular carcinoma
|
Tashiro, Jun |
|
2002 |
3 |
1 |
p. 19-20 2 p. |
artikel |
16 |
Routine long-term androgen suppression following standard radiotherapy improves disease-free survival in men with unfavourable-prognosis prostate cancer compared with relapse-initiated therapy
|
Kellokumpu-Lehtinen, Pirkko |
|
2002 |
3 |
1 |
p. 46-47 2 p. |
artikel |
17 |
Seven years of tamoxifen no better than 5 years among women with estrogen receptor-positive breast cancer and negative axillary nodes
|
Holli, Kaija |
|
2002 |
3 |
1 |
p. 27-28 2 p. |
artikel |
18 |
Table A. Levels of evidence and grades of recommendations
|
|
|
2002 |
3 |
1 |
p. 50- 1 p. |
artikel |
19 |
The effects of adjuvant high-dose medroxyprogesterone acetate are dependent on the population subgroup among women with breast cancer
|
Shapiro, Charles L. |
|
2002 |
3 |
1 |
p. 24-26 3 p. |
artikel |
20 |
Tumor cell aneuploidy is associated with poorer survival than near-diploidy in people with resected non-small-cell lung cancer
|
Cohen, Victor |
|
2002 |
3 |
1 |
p. 9-10 2 p. |
artikel |
21 |
Vigorous activity may be associated with a modest increase in the risk of ovarian cancer
|
Rockhill, Beverly |
|
2002 |
3 |
1 |
p. 7-8 2 p. |
artikel |
22 |
Women at higher risk of breast cancer are more likely to attend population-based breast screening programmes
|
Asch, Bonnie B. |
|
2002 |
3 |
1 |
p. 11- 1 p. |
artikel |